Laura Clague Insider Trading $RTRX Travere Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Laura Clague.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Laura Clague. Laura Clague is Director in LRAD Corp ($LRAD) and Director in FLUIDIGM CORP ($FLDM) and Chief Financial Officer in Retrophin, Inc. ($RTRX).

Laura Clague in Travere Therapeutics, Inc.

Trading Symbol: RTRX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Laura Clague: Chief Financial Officer
Holdings: 30,223 shares
Current Value: $606,576
Latest Transaction: May 13 2021
$RTRX Market Capitalization: $766.34M
$RTRX Previous Close: $20.07

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Laura Clague in Travere Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, FLDM, LRAD, RTRX

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 13 2021RTRXTravere Therapeuti ...Clague LauraChief Financial Off ...SellS19.462,00038,92028,22330.2 K to 28.2 K (-6.62 %)
May 13 2021RTRXTravere Therapeuti ...Clague LauraChief Financial Off ...SellS19.142,00038,28030,22332.2 K to 30.2 K (-6.21 %)
Feb 09 2021RTRXTravere Therapeuti ...Clague LauraChief Financial Off ...SellS31.582,25071,05532,22334.5 K to 32.2 K (-6.53 %)
Feb 09 2021RTRXTravere Therapeuti ...Clague LauraChief Financial Off ...SellS31.412,25070,67334,47336.7 K to 34.5 K (-6.13 %)
Feb 05 2021RTRXTravere Therapeuti ...Clague LauraChief Financial Off ...GrantA0.004,500036,72332.2 K to 36.7 K (+13.97 %)
Feb 05 2021RTRXTravere Therapeuti ...Clague LauraChief Financial Off ...GrantA0.004,500036,72332.2 K to 36.7 K (+13.97 %)
Feb 03 2021RTRXTravere Therapeuti ...Clague LauraChief Financial Off ...SellS28.911,12532,52432,22333.3 K to 32.2 K (-3.37 %)
Feb 03 2021RTRXTravere Therapeuti ...Clague LauraChief Financial Off ...SellS28.912,50072,27533,34835.8 K to 33.3 K (-6.97 %)
Feb 02 2021RTRXTravere Therapeuti ...Clague LauraChief Financial Off ...SellS30.751,12534,59435,84837 K to 35.8 K (-3.04 %)
Feb 02 2021RTRXTravere Therapeuti ...Clague LauraChief Financial Off ...SellS30.752,50076,87536,97339.5 K to 37 K (-6.33 %)
Feb 02 2021RTRXTravere Therapeuti ...Clague LauraChief Financial Off ...GrantA0.005,000039,47334.5 K to 39.5 K (+14.50 %)
Jan 25 2021RTRXTravere Therapeuti ...Clague LauraChief Financial Off ...Option ExerciseA26.8857,5001,545,60057,500
Jan 25 2021RTRXTravere Therapeuti ...Clague LauraChief Financial Off ...GrantA0.0015,000034,47319.5 K to 34.5 K (+77.03 %)
Nov 17 2020RTRXTravere Therapeuti ...Clague LauraChief Financial Off ...SellS23.987,500179,81319,47327 K to 19.5 K (-27.81 %)
Nov 13 2020RTRXRetrophin, Inc.Clague LauraChief Financial Off ...SellS23.617,500177,07126,97334.5 K to 27 K (-21.76 %)
Nov 13 2020RTRXRetrophin, Inc.Clague LauraChief Financial Off ...GrantA0.0015,000034,47319.5 K to 34.5 K (+77.03 %)
Sep 23 2020RTRXRetrophin, Inc.Clague LauraChief Financial Off ...SellS18.481,50027,72019,47321 K to 19.5 K (-7.15 %)
Sep 22 2020RTRXRetrophin, Inc.Clague LauraChief Financial Off ...SellS18.591,50027,88520,97322.5 K to 21 K (-6.67 %)
Sep 22 2020RTRXRetrophin, Inc.Clague LauraChief Financial Off ...GrantA0.003,000022,47319.5 K to 22.5 K (+15.41 %)
Sep 22 2020RTRXRetrophin, Inc.Clague LauraChief Financial Off ...SellS18.591,50027,88520,97322.5 K to 21 K (-6.67 %)
Sep 22 2020RTRXRetrophin, Inc.Clague LauraChief Financial Off ...GrantA0.003,000022,47319.5 K to 22.5 K (+15.41 %)
May 13 2020RTRXRetrophin, Inc.Clague LauraChief Financial Off ...SellS16.985278,95119,47320 K to 19.5 K (-2.63 %)
May 13 2020RTRXRetrophin, Inc.Clague LauraChief Financial Off ...SellS17.161,25021,45020,00021.3 K to 20 K (-5.88 %)
May 13 2020RTRXRetrophin, Inc.Clague LauraChief Financial Off ...SellS14.951,25018,68821,25022.5 K to 21.3 K (-5.56 %)
May 13 2020RTRXRetrophin, Inc.Clague LauraChief Financial Off ...SellS16.985278,95119,47320 K to 19.5 K (-2.63 %)
May 13 2020RTRXRetrophin, Inc.Clague LauraChief Financial Off ...SellS17.161,25021,45020,00021.3 K to 20 K (-5.88 %)
May 13 2020RTRXRetrophin, Inc.Clague LauraChief Financial Off ...SellS14.951,25018,68821,25022.5 K to 21.3 K (-5.56 %)
Mar 12 2020RTRXRetrophin, Inc.Clague LauraChief Financial Off ...SellS15.024,00060,08022,50026.5 K to 22.5 K (-15.09 %)
Mar 09 2020RTRXRetrophin, Inc.Clague LauraChief Financial Off ...GrantA0.004,000026,50022.5 K to 26.5 K (+17.78 %)
Jan 31 2020RTRXRetrophin, Inc.Clague LauraChief Financial Off ...Option ExerciseA0.0010,000010,000
Jan 31 2020RTRXRetrophin, Inc.Clague LauraChief Financial Off ...Option ExerciseA0.009,00009,000
Jan 31 2020RTRXRetrophin, Inc.Clague LauraChief Financial Off ...Option ExerciseA15.4655,000850,30055,000
Jan 31 2020RTRXRetrophin, Inc.Clague LauraChief Financial Off ...GrantA0.009,000022,50013.5 K to 22.5 K (+66.67 %)
May 16 2019RTRXRetrophin, Inc.Clague LauraChief Financial Off ...SellS18.711,25023,38813,50014.8 K to 13.5 K (-8.47 %)
May 16 2019RTRXRetrophin, Inc.Clague LauraChief Financial Off ...SellS17.781,25022,22514,75016 K to 14.8 K (-7.81 %)
May 10 2019RTRXRetrophin, Inc.Clague LauraChief Financial Off ...Option ExerciseA0.006,00006,000
May 10 2019RTRXRetrophin, Inc.Clague LauraChief Financial Off ...Option ExerciseA0.006,00006,000
May 10 2019RTRXRetrophin, Inc.Clague LauraChief Financial Off ...Option ExerciseA17.9640,000718,40040,000
May 10 2019RTRXRetrophin, Inc.Clague LauraChief Financial Off ...Option ExerciseA17.9640,000718,40040,000
May 10 2019RTRXRetrophin, Inc.Clague LauraChief Financial Off ...GrantA0.006,000016,00010 K to 16 K (+60.00 %)
May 10 2019RTRXRetrophin, Inc.Clague LauraChief Financial Off ...GrantA0.006,000016,00010 K to 16 K (+60.00 %)
Feb 13 2019RTRXRetrophin, Inc.Clague LauraChief Financial Off ...SellS21.501,01621,84410,00011 K to 10 K (-9.22 %)
Feb 13 2019RTRXRetrophin, Inc.Clague LauraChief Financial Off ...SellS21.381,01721,74311,01612 K to 11 K (-8.45 %)
Dec 21 2018RTRXRetrophin, Inc.Clague LauraChief Financial Off ...SellS22.3490020,10912,03312.9 K to 12 K (-6.96 %)
Dec 21 2018RTRXRetrophin, Inc.Clague LauraChief Financial Off ...SellS21.672,85061,75112,93315.8 K to 12.9 K (-18.06 %)
Dec 21 2018RTRXRetrophin, Inc.Clague LauraChief Financial Off ...SellS22.083,75082,80515,78319.5 K to 15.8 K (-19.20 %)
Dec 20 2018RTRXRetrophin, Inc.Clague LauraChief Financial Off ...GrantA0.007,500019,53312 K to 19.5 K (+62.33 %)
Nov 16 2018RTRXRetrophin, Inc.Clague LauraChief Financial Off ...SellS24.7379119,56212,03312.8 K to 12 K (-6.17 %)
Nov 16 2018RTRXRetrophin, Inc.Clague LauraChief Financial Off ...SellS24.202,95971,60512,82415.8 K to 12.8 K (-18.75 %)
Nov 16 2018RTRXRetrophin, Inc.Clague LauraChief Financial Off ...SellS24.544009,81615,78316.2 K to 15.8 K (-2.47 %)
Nov 16 2018RTRXRetrophin, Inc.Clague LauraChief Financial Off ...SellS23.633,35079,15416,18319.5 K to 16.2 K (-17.15 %)
May 14 2018RTRXRetrophin, Inc.Clague LauraChief Financial Off ...Option ExerciseA0.008,00008,000
May 14 2018RTRXRetrophin, Inc.Clague LauraChief Financial Off ...Option ExerciseA25.2548,0001,212,00048,000
May 14 2018RTRXRetrophin, Inc.Clague LauraChief Financial Off ...GrantA0.0010,000012,0332 K to 12 K (+491.88 %)
Feb 12 2018RTRXRetrophin, Inc.Clague LauraChief Financial Off ...GrantA0.002,03302,0330 to 2 K
May 18 2017RTRXRetrophin, Inc.Clague LauraChief Financial Off ...Option ExerciseA17.4460,0001,046,40060,000
May 23 2016RTRXRetrophin, Inc.Clague LauraChief Financial Off ...Option ExerciseA16.2360,000973,80060,000
Jul 06 2015RTRXRetrophin, Inc.Clague LauraChief Financial Off ...Option ExerciseA32.4960,0001,949,40060,000

Page:   1

Contact us | Follow us on Twitter